Precision Biosciences Inc. (DTIL)
NASDAQ · Healthcare
Precision Biosciences Inc. Revenue 2018–2025
Precision Biosciences Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Precision Biosciences Inc. revenue for the quarter ending March 31, 2026 was 10.8 M, a 37272.41% increase year-over-year.
- Precision Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 10.9 M, a 86.58% decrease year-over-year.
- Precision Biosciences Inc. annual revenue for 2025 was 34.3 M, a 50.12% decrease from 2024.
- Precision Biosciences Inc. annual revenue for 2024 was 68.7 M, a 40.98% increase from 2023.
- Precision Biosciences Inc. annual revenue for 2023 was 48.7 M, a 94.15% increase from 2022.
- Precision Biosciences Inc. annual revenue for 2022 was 25.1 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Precision Biosciences Inc. Market Cap — FAQ
Precision Biosciences Inc. (DTIL) market cap over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DTIL's market cap history?
The chart and table above show Precision Biosciences Inc.'s market cap by year and by quarter, including the growth rate.